Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
Saved in:
| Title: | Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. |
|---|---|
| Authors: | Hanna GJ; Department of Medical Oncology, Dana-Faber Cancer Institute, Boston, Massachusetts., Zamulko OY; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Grover P; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Adkins DR; Robert Ebert and Greg Stubblefield Head and Neck Tumor Center at Washington University School of Medicine, Alvin J. Siteman Cancer Center, and Barnes-Jewish Hospital, St. Louis, Missouri., Oppelt PJ; Robert Ebert and Greg Stubblefield Head and Neck Tumor Center at Washington University School of Medicine, Alvin J. Siteman Cancer Center, and Barnes-Jewish Hospital, St. Louis, Missouri., Romano AE; University of Cincinnati Cancer Center, Cincinnati, Ohio., Lehn MA; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Bachmann LM; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Wikenheiser-Brokamp KA; University of Cincinnati Medical Center, Cincinnati, Ohio., Lemmon CA; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Forsythe AJ; University of Cincinnati Cancer Center, Cincinnati, Ohio., Allen CL; University of Cincinnati Cancer Center, Cincinnati, Ohio., Pan J; Biostatistics and Informatics Shared Resource, University of Cincinnati Cancer Center, Cincinnati, Ohio.; Cancer Data Science Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.; Department of Biostatistics, Health Informatics and Data Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio., Rai SN; Biostatistics and Informatics Shared Resource, University of Cincinnati Cancer Center, Cincinnati, Ohio.; Cancer Data Science Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.; Department of Biostatistics, Health Informatics and Data Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio., El-Gamal D; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Wise-Draper TM; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio. |
| Source: | JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2026 Apr 01; Vol. 152 (4), pp. 376-383. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589542 Publication Model: Print Cited Medium: Internet ISSN: 2168-619X (Electronic) Linking ISSN: 21686181 NLM ISO Abbreviation: JAMA Otolaryngol Head Neck Surg Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-619X |
|---|---|
| DOI: | 10.1001/jamaoto.2025.5404 |
